CHINA BIOLOGIC PRODS INC's ticker is CBPOXXXX and the CUSIP is 16938C106. A total of 6 filers reported holding CHINA BIOLOGIC PRODS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $12,441,000 | -32.8% | 110,000 | -40.5% | 0.17% | -19.7% |
| Q1 2017 | $18,511,000 | -36.2% | 185,000 | -31.5% | 0.21% | -63.8% |
| Q4 2016 | $29,032,000 | -13.7% | 270,140 | 0.0% | 0.59% | -28.8% |
| Q3 2016 | $33,627,000 | +24.5% | 270,140 | +6.3% | 0.83% | +30.3% |
| Q2 2016 | $27,013,000 | -1.5% | 254,140 | +6.0% | 0.63% | +8.9% |
| Q1 2016 | $27,411,000 | -10.3% | 239,840 | +11.6% | 0.58% | +6.6% |
| Q4 2015 | $30,570,000 | +56.1% | 214,840 | -1.2% | 0.55% | +57.8% |
| Q3 2015 | $19,580,000 | -14.4% | 217,481 | +9.4% | 0.35% | -7.7% |
| Q2 2015 | $22,885,000 | +124.7% | 198,866 | +86.1% | 0.38% | +74.4% |
| Q1 2015 | $10,184,000 | +42.9% | 106,866 | 0.0% | 0.22% | +61.7% |
| Q4 2014 | $7,126,000 | +40.8% | 106,866 | +13.6% | 0.13% | +14.7% |
| Q3 2014 | $5,061,000 | +21.0% | 94,045 | 0.0% | 0.12% | -6.5% |
| Q2 2014 | $4,182,000 | – | 94,045 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WARBURG PINCUS LLC | 10,989,200 | $1,049,578,000 | 7.88% |
| RUDMAN ERROL M | 110,201 | $10,525,000 | 3.65% |
| Ativo Capital Management LLC | 59,789 | $5,710,000 | 2.24% |
| OBERWEIS ASSET MANAGEMENT INC/ | 56,200 | $5,368,000 | 1.51% |
| Granite Point Capital Management, L.P. | 40,000 | $3,820,000 | 1.40% |
| Cormorant Asset Management, LP | 76,500 | $7,307,000 | 1.13% |
| Spark Investment Management LLC | 52,800 | $5,031,000 | 0.70% |
| Grandeur Peak Global Advisors, LLC | 33,050 | $3,157,000 | 0.67% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 198,454 | $18,954,000 | 0.66% |
| Visium Asset Management, LP | 438,008 | $41,834,000 | 0.62% |